Clinical trial
Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
NCT00133874 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00133874 |
|---|---|
| Title | Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo |
| Official title | An Observer-blind, Multicenter, Non-inferiority, Comparative Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, Versus Topical 2% Fusidic Acid Cream Applied Three Times Daily for 7 Days in the Treatment Adult and Paediatric Subjects With Impetigo |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Skin Infections, Bacterial |
| Intervention type | Drug |
| Interventions | SB-275833 ointment, 1% |
| Enrollment | 520 |
| Start date | Apr 1, 2005 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Aug 24, 2005 |
| Last update posted | Jan 23, 2017 |
| Countries | Canada, Costa Rica, France, Germany, India, Mexico, Netherlands, Peru, Poland, South Africa |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: